SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of September 30, 2024: Q3 2024
Type / Class: Debt / NOTE 1.250% 9/1
Principal, excl. options Q3 2024: 935M
Holdings value Q3 2024: $1.1B
Value change Q3 2024: -$3.34M
Grand Portfolio weight change Q3 2024: 0%
Number of holders: 71
Number of buys Q3 2024: 26
Number of sells Q3 2024: -34
Average buys Q3 2024 %: +0.001%
Average sells Q3 2024 %: -0.001%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Principal	Value	Change	Price	Investors
2024 Q3	$935M	$1.1B	-$3.34M	$1.14	71
2024 Q2	$955M	$1.27B	-$95.2M	$1.29	74
2024 Q1	$1.01B	$1.18B	-$16M	$1.17	61
2023 Q4	$1.04B	$1.06B	+$76.4M	$1.01	63
2023 Q3	$955M	$1.08B	+$1.08B	$1.12	62